Product Information
DuraPlug™ Synthetic Extended Temporary Punctal/Canalicular Insert – Multiple Sizes
Brand: DuraPlug™
Size: 0.4mm diameter x 2.0mm length
Product Description:
DuraPlug™ extended temporary punctal/canalicular inserts are designed for temporary occlusion of the tear ducts, offering targeted relief for a range of ocular surface conditions. These synthetic plugs are ideal for:
-
Post-LASIK induced dry eye
-
Seasonal dry eye
-
Prolonged retention of ocular medications
Each plug remains effective for 60 to 180 days, delivering reliable performance and comfort for patients in need of medium-term tear duct occlusion.
Product Features:
-
Size: 0.2mm -0.5mm
-
Duration: Effective for 60–180 days
-
Sterile packaging: 2 inserts per sterile pouch
-
10 packages per box
-
5-year shelf life
Available Sizes:
-
0.2mm x 2.0mm
-
0.3mm x 2.0mm
-
0.4mm x 2.0mm
-
0.5mm x 2.0mm
Indication:
Temporary punctal occlusion for dry eye management and ocular drug retention.
RescueRating RR 42 out of 100 Evidence: LimitedHow we rated itHide details
How DuraPlug earned RR 42
In-office product: rated on published research and doctor adoption, each scored out of 100 within punctal plugs.
- Published research508 scored studies; evidence limited
- Doctor adoption34#4 of 7 in punctal plugs by ordering practices
Published research50 / 100
- What was studied
- Temporary occlusion of the tear drainage canal (cleared use)
- Match to this product
- Related ingredient or device studies, weighted lower
-
Meta-analysisClin Ophthalmol, 2026
Efficacy of Punctal Occlusion Techniques in Tear Drainage Disorders: A Systematic Review and Meta-Analysis
No significant improvement in TBUT, Schirmer or staining versus controls.
-
Randomized trialFront Med (Lausanne), 2026
Enhanced efficacy of 0.05% cyclosporine A combined with absorbable punctal plugs in Sjogren's syndrome-associated dry eye: a paired-eye clinical trial
Adding an absorbable plug to cyclosporine gave larger gains in NIBUT, tear meniscus and symptom scores than cyclosporine alone at 3 months.
-
Meta-analysisCont Lens Anterior Eye, 2025
How effective and safe are punctal plugs in treating dry eye disease? A systematic review and meta-analysis
Pooled improvements in TBUT, Schirmer, OSDI and staining, with 86% retention.
-
Randomized trialFront Med (Lausanne), 2021
Treatment of Dry Eye With Intracanalicular Injection of Hydroxybutyl Chitosan: A Prospective Randomized Clinical Trial
Within the absorbable plug arm, OSDI, phenol red thread and tear meniscus improved from baseline but staining and TBUT did not; no placebo arm.
Study results describe the people studied. They do not predict how any one patient will respond.
Doctor adoption34 / 100
- Rank in category
- #4 of 7 by ordering practices
- Ordering practices
- 11 in 92 days
- Repeat orders
- 1 repeat order from 11 practices in 92 days
- Window
- 11 Aug to 10 Nov 2026
Orders and reorders from practices in the Dry Eye Rescue network only, ranked within punctal plugs.
Sources and methodHow we got this
- Research: peer-reviewed studies from PubMed and other medical indexes, scored by our clinical team on how closely each matches this product.
- Doctor adoption: Dry Eye Rescue wholesale orders and reorders, ranked within punctal plugs.
- In-office products have no patient purchases or reviews, so the RescueRating averages research and doctor adoption.
- Schedule: re-rated every quarter. Changes of 5 points or more are checked by our team before they go live.
CLINIC ESSENTIALS
Add the Rx You Use Every Day
Already ordering your OTC inventory? Add commonly used clinic medications to the same order.
NDC 24208-730-06
NDC 24208-585-64
![Tobramycin Dexamethasone [TOBRADEX] 0.3%/0.1% 2.5mL](http://wholesale.dryeyerescue.com/cdn/shop/files/RX-1056-Tobramycin-Dexamethasone-01.jpg?v=1784151141&width=480)
NDC 24208-295-25
More from Corza Medical
Explore more products from the same brand.
Practices also stock
Complementary products other practices order alongside this one.
